Key facts
- This page summarizes Mark Mcdade's Form 4 filing for Tourmaline Bio, Inc. (TRML).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 31 Jan 2024, 16:26.
Mark Mcdade - 29 Jan 2024 Form 4 Insider Report for Tourmaline Bio, Inc. (TRML)
- Reporting relationship
- Director
- Issuer ticker
- TRML
- Reported as of
- 29 Jan 2024
- Net transaction value
- +$3,250,000
- SEC form
- 4
- Accepted by SEC
- 31 Jan 2024, 16:26:17 UTC
- Prior SEC filing
- 23 Oct 2023
- Next SEC filing
- 20 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark McDade
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark Mcdade filed Form 4 for Tourmaline Bio, Inc. (TRML) on 31 Jan 2024.
Change
- Previous filing in this sequence was filed on 23 Oct 2023.
- Current net transaction value: +$3,250,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TRML
transaction
Common Stock
Purchase
- Transaction value
- $3,250,000
- Shares
- +100,000
- Change %
- +29%
- Price
- $32.50
- Shares after
- 448,431
- Date
- 29 Jan 2024
- Ownership
- By Qiming U.S. Healthcare Fund III,L.P.
- Footnotes
- F1
TRML
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 518
- Date
- 29 Jan 2024
- Ownership
- Direct
TRML
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 183,177
- Date
- 29 Jan 2024
- Ownership
- By Qiming U.S. Healthcare Fund I,L.P.
- Footnotes
- F2
TRML
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 110,083
- Date
- 29 Jan 2024
- Ownership
- By Qiming U.S. Healthcare Fund II,L.P.
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The securities are directly held by Qiming U.S. Healthcare Fund III, L.P. ("Qiming III"). Qiming U.S. Healthcare GP III, LLC ("Qiming GP III") is the sole general partner of Qiming III. The Reporting Person is a managing member of Qiming GP III and may be deemed to share voting and dispositive power over the securities held by Qiming III. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
Footnote F2
The securities are directly held by Qiming U.S. Healthcare Fund I, L.P. ("Qiming"). Qiming U.S. Healthcare GP I, LLC ("Qiming GP") is the sole general partner of Qiming. The Reporting Person is a managing member of Qiming GP and may be deemed to share voting and dispositive power over the securities held by Qiming. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
Footnote F3
The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming II"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP II") is the sole general partner of Qiming II. The Reporting Person is a managing member of Qiming GP II and may be deemed to share voting and dispositive power over the securities held by Qiming II. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.